Regulatory T cells exert checks and balances on self tolerance and autoimmunity

Nature Immunology

Volumn 11, Issue 1, 2010, Pages 7-13

  Wing, Kajsa ^a,c   Sakaguchi, Shimon ^a,b  

^a KYOTO UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN EXPRESSION; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BACTERIAL INFECTION; CD4+ CD25+ T LYMPHOCYTE; GENE MUTATION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; LYMPHOCYTE FUNCTION; LYMPHOCYTOPOIESIS; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; T CELL DEPLETION; T LYMPHOCYTE ACTIVATION; THYMUS; ANIMAL; BIOLOGICAL MODEL; DENDRITIC CELL; IMMUNOLOGY; T LYMPHOCYTE;

CYTOKINE;

ANIMALS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; CYTOKINES; DENDRITIC CELLS; HUMANS; MODELS, IMMUNOLOGICAL; SELF TOLERANCE; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY;

EID: 74049164847     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.1818     Document Type: Review

References (101)

1. Ehrlich, P. collected Papers of Paul ehrlich vol.2 (Pergamon, New York, 1957).
2. Burnet, F.M. The clonal Selection Theory of acquired Immunity (Cambridge University Press, Cambridge, UK, 1959).
3. Nossal, G.J. Clonal anergy of B cells: a flexible, reversible, and quantitative concept. J. Exp. Med. 183, 1953-1956 (1996).
4. Sakaguchi, S., wing, K. & Miyara, M. Regulatory T cells-a brief history and perspective. Eur. J. Immunol. 37 (suppl. 1), S116-S123 (2007).
5. Gershon, R.K. & Kondo, K. Cell Interactions in the induction of tolerance: the role of thymic lymphocytes. Immunology 18, 723-737 (1970).
6. Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M. & Toda, M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoImmune diseases. J. Immunol. 155, 1151-1164 (1995).
7. + Regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 6, 345-352 (2005).
8. Izcue, A., Coombes, J.L. & Powrie, F. Regulatory lymphocytes and intestinal inflammation. Annu. Rev. Immunol. 27, 313-338 (2009).
9. Singh, B. et al. Control of intestinal inflammation by Regulatory T cells. Immunol. Rev. 182, 190-200 (2001).
10. Hori, S., Nomura, T. & Sakaguchi, S. Control of Regulatory T cell development by the transcription factor Foxp3. Science 299, 1057-1061 (2003).
11. + T Regulatory cells. Nat. Immunol. 4, 337-342 (2003).
12. + Regulatory T cells. Nat. Immunol. 4, 330-336 (2003).
13. Gambineri, E., Torgerson, T. & Ochs, H. Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPeX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis. Curr. opin. rheumatol. 15, 430-435 (2003).
14. WILdin, R.S., Smyk-Pearson, S. & FILipovich, A.H. Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPeX) syndrome. J. Med. Genet. 39, 537-545 (2002).
15. Itoh, M. et al. Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J. Immunol. 162, 5317-5326 (1999).
16. Klein, L. & Kyewski, B. Self-antigen presentation by thymic stromal cells: a subtle division of labor. Curr. opin. Immunol. 12, 179-186 (2000).
17. Gambineri, E. et al. Clinical and molecular profILe of a new series of patients with Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: inconsistent correlation between forkhead box protein 3 expression and disease severity. J. allergy Clin. Immunol. 122, 1105-1112.e1 (2008).
18. Danke, N.A., Koelle, D.M., Yee, C., Beheray, S. & Kwok, W.W. Autoreactive T cells in healthy individuals. J. Immunol. 172, 5967-5972 (2004).
19. Wing, K. et al. CD4 T cell activation by myelin oligodendrocyte glycoprotein is suppressed by adult but not cord blood CD25+ T cells. Eur. J. Immunol. 33, 579-587 (2003).
20. + Regulatory T cells. Eur. J. Immunol. 32, 1621-1630 (2002).
21. Gnjatic, S. et al. NY-eSO-1 DNA vaccine induces T-cell responses that are suppressed by Regulatory T cells. Clin. cancer res. 15, 2130-2139 (2009).
22. Danke, N.A., Yang, J., Greenbaum, C. & Kwok, W.W. Comparative study of GAD65-specific CD4+ T cells in healthy and type 1 diabetic subjects. J. autoimmun. 25, 303-311 (2005).
23. Yang, J. et al. CD4+ T cells from type 1 diabetic and healthy subjects exhibit different thresholds of activation to a naturally processed proinsulin epitope. J. autoimmun. 31, 30-41 (2008).
24. Baxter, A.G. The origin and application of experimental autoImmune encephalomy-elitis. Nat. Rev. Immunol. 7, 904-912 (2007).
25. Zaccone, P. et al. AutoImmune thyroid disease induced by thyroglobulin and lipopoly-saccharide is inhibited by soluble TNF receptor type I. Eur. J. Immunol. 32, 1021-1028 (2002).
26. Eriksson, U. et al. Dendritic cell-induced autoImmune heart faILure requires cooperation between adaptive and innate immunity. Nat. Med. 9, 1484-1490 (2003).
27. Watanabe, H. et al. experimental autoImmune thyroiditis induced by thyroglobulin-pulsed dendritic cells. autoimmunity 31, 273-282 (1999).
28. Gehring, A.J. et al. The Mycobacterium tuberculosis 19-kILodalton lipoprotein inhibits gamma Interferon-regulated HLA-Dr and Fc gamma r1 on human macrophages through Toll-like receptor 2. Infect. Immun. 71, 4487-4497 (2003).
29. Rose, N.R., Twarog, F.J. & Crowle, A.J. Murine thyroiditis: importance of adjuvant and mouse strain for the induction of thyroid lesions. J. Immunol. 106, 698-704 (1971).
30. McGeachy, M.J., Stephens, L.A. & Anderton, S.M. Natural recovery and protection from autoImmune encephalomyelitis: contribution of CD4+CD25+ Regulatory cells within the central nervous system. J. Immunol. 175, 3025-3032 (2005).
31. Korn, T. et al. Myelin-specific Regulatory T cells accumulate in the CNS but faIL to control autoImmune inflammation. Nat. Med. 13, 423-431 (2007).
32. + Regulatory T cells suppress antigen-specific autoreactive Immune responses and central nervous system inflammation during active experimental autoImmune encephalo-myelitis. J. Immunol. 169, 4712-4716 (2002).
33. Morris, G.P., Yan, Y., David, C.S. & Kong, Y.M. H2A-and H2e-derived CD4+CD25+ Regulatory T cells: a potential role in reciprocal Inhibition by class II genes in autoImmune thyroiditis. J. Immunol. 174, 3111-3116 (2005).
34. Reddy, J. et al. Myelin proteolipid protein-specific CD4+CD25+ Regulatory cells mediate genetic resistance to experimental autoImmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 101, 15434-15439 (2004).
35. Takahashi, T. et al. Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoImmune disease by breaking their anergic/suppressive state. Int. Immunol. 10, 1969-1980 (1998).
36. Kim, J.M., Rasmussen, J.P. & Rudensky, A.Y. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat. Immunol. 8, 191-197 (2007).
37. Lahl, K. et al. Selective depletion of Foxp3+ Regulatory T cells induces a scurfy-like disease. J. Exp. Med. 204, 57-63 (2007).
38. Fontenot, J.D., Dooley, J.L., Farr, A.G. & Rudensky, A.Y. Developmental regulation of Foxp3 expression during ontogeny. J. Exp. Med. 202, 901-906 (2005).
39. Gavin, M.A. et al. Foxp3-dependent programme of Regulatory T-cell differentiation. Nature 445, 771-775 (2007).
40. Lin, W. et al. Regulatory T cell development in the absence of functional Foxp3. Nat. Immunol. 8, 359-368 (2007).
41. + Regulatory T cells induced by an agonist self-peptide. Nat. Immunol. 2, 301-306 (2001).
42. Kawahata, K. et al. Generation of CD4+CD25+ Regulatory T cells from autoreactive T cells simultaneously with their negative selection in the thymus and from nonau-toreactive T cells by endogenous TCr expression. J. Immunol. 168, 4399-4405 (2002).
43. Van Santen, H.-M., Benoist, C. & Mathis, D. Number of T reg cells that differentiate does not increase upon encounter of agonist ligand on thymic epithelial cells. J. Exp. Med. 200, 1221-1230 (2004).
44. Pennington, D.J. et al. Early events in the thymus affect the balance of Effector and Regulatory T cells. Nature 444, 1073-1077 (2006).
45. + T cell receptors. Immunity 21, 267-277 (2004).
46. Pacholczyk, R., Ignatowicz, H., Kraj, P. & Ignatowicz, L. Origin and T cell receptor diversity of Foxp3+CD4+CD25+ T cells. Immunity 25, 249-259 (2006).
47. Pacholczyk, R. et al. Nonself-antigens are the cognate specificities of Foxp3+ Regulatory T cells. Immunity 27, 493-504 (2007).
48. Wong, J. et al. Adaptation of TCr repertoires to self-peptides in Regulatory and nonRegulatory CD4+ T cells. J. Immunol. 178, 7032-7041 (2007).
49. Bautista, J.L. et al. Intraclonal competition limits the fate determination of Regulatory T cells in the thymus. Nat. Immunol. 10, 610-617 (2009).
50. DiPaolo, R.J. & Shevach, E.M. CD4+ T-cell development in a mouse expressing a transgenic TCr derived from a Treg. Eur. J. Immunol. 39, 234-240 (2009).
51. Sakaguchi, S., Yamaguchi, T., Nomura, T. & Ono, M. Regulatory T cells and Immune tolerance. Cell 133, 775-787 (2008).
52. Akiyama, T. et al. Dependence of self-tolerance on TrAF6-directed development of thymic stroma. Science 308, 248-251 (2005).
53. Kajiura, F. et al. NF-kappa B-inducing kinase establishes self-tolerance in a thymic stroma-dependent manner. J. Immunol. 172, 2067-2075 (2004).
54. + immunoRegulatory T cells. J. Exp. Med. 194, 427-438 (2001).
55. + Regulatory T cells in human thymus. Nature 436, 1181-1185 (2005).
56. Anderson, M.S. et al. Projection of an immunological self shadow within the thymus by the aire protein. Science 298, 1395-1401 (2002).
57. Kuroda, N. et al. Development of autoimmunity against transcriptionally unrepressed target antigen in the thymus of Aire-deficient mice. J. Immunol. 174, 1862-1870 (2005).
58. + medullary thymic epithelial cells. Nat. Immunol. 8, 351-358 (2007).
59. Kekäläinen, E. et al. A defect of Regulatory T cells in patients with autoImmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J. Immunol. 178, 1208-1215 (2007).
60. Wing, K., Fehervari, Z. & Sakaguchi, S. Emerging possibILities in the development and function of Regulatory T cells. Int. Immunol. 18, 991-1000 (2006).
61. Komatsu, N. et al. Heterogeneity of natural Foxp3+ T cells: a committed Regulatory T-cell lineage and an uncommitted minor population retaining plasticity. Proc. Natl. Acad. Sci. USA 106, 1903-1908 (2009).
62. Duarte, J.H., Zelenay, S., Bergman, M., Martins, A.C. & Demengeot, J. Natural Treg cells spontaneously differentiate into pathogenic helper cells in lymphopenic conditions. Eur. J. Immunol. 39, 948-955 (2009).
63. Wan, Y.Y. & Flavell, R.A. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature 445, 766-770 (2007).
64. Zhou, X. et al. InstabILity of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat. Immunol. 10, 1000-1007 (2009).
65. Shevach, E.M. Mechanisms of foxp3+ T Regulatory cell-mediated suppression. Immunity 30, 636-645 (2009).
66. Vignali, D.A.A., Collison, L.W. & Workman, C.J. How Regulatory T cells work. Nat. Rev. Immunol. 8, 523-532 (2008).
67. + Regulatory T cell: a jack of all trades, master of regulation. Nat. Immunol. 9, 239-244 (2008).
68. Salomon, B. et al. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoRegulatory T cells that control autoImmune diabetes. Immunity 12, 431-440 (2000).
69. Read, S., Malmstrom, V. & Powrie, F. Cytotoxic T lymphocyte- associated antigen 4 plays an essential role in the function of CD25+CD4+ Regulatory cells that control intestinal inflammation. J. Exp. Med. 192, 295-302 (2000).
70. Takahashi, T. et al. Immunologic self-tolerance maintained by CD25+CD4+ Regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 192, 303-310 (2000).
71. + T cells expressing the FoxP3 transcription factor. Immunity 30, 899-911, doi:10.1016/j.immunI.2009.03.019 (2009).
72. Lühder, F., Höglund, P., Allison, J.P., Benoist, C. & Mathis, D. Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) regulates the unfolding of autoImmune diabetes. J. Exp. Med. 187, 427-432 (1998).
73. Marson, A. et al. Foxp3 occupancy and regulation of key target genes during T-cell stimulation. Nature 445, 931-935 (2007).
74. Zheng, Y. et al. Genome-wide analysis of Foxp3 target genes in developing and mature Regulatory T cells. Nature 445, 936-940 (2007).
75. Wu, Y. et al. FOXP3 controls Regulatory T cell function through cooperation with NFAT. Cell 126, 375-387 (2006).
76. Ono, M. et al. Foxp3 controls Regulatory T-cell function by interacting with AML1/ runx1. Nature 446, 685-689 (2007).
77. Wing, K. et al. CTLA-4 control over Foxp3+ Regulatory T cell function. Science 322, 271-275 (2008).
78. Onishi, Y., Fehervari, Z., Yamaguchi, T. & Sakaguchi, S. Foxp3+ natural Regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation. Proc. Natl. Acad. Sci. USA 105, 10113-10118 (2008).
79. Grohmann, U. et al. CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat. Immunol. 3, 1097-1101 (2002).
80. Dejean, A.S. et al. Transcription factor Foxo3 controls the magnitude of T cell Immune responses by modulating the function of dendritic cells. Nat. Immunol. 10, 504-513 (2009).
81. Tang, Q. et al. Visualizing Regulatory T cell control of autoImmune responses in nonobese diabetic mice. Nat. Immunol. 7, 83-92 (2006).
82. + T cells and dendritic cells in vivo. J. Exp. Med. 203, 505-511 (2006).
83. - precursor cells in the absence of interleukin 10. Nat. Immunol. 8, 931-941 (2007).
84. Rubtsov, Y.P. et al. Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 28, 546-558 (2008).
85. Cao, X. et al. Granzyme B and perforin are important for Regulatory T cell-mediated suppression of tumor clearance. Immunity 27, 635-646 (2007).
86. Koch, M.A. et al. The transcription factor T-bet controls Regulatory T cell homeostasis and function during type 1 inflammation. Nat. Immunol. 10, 595-602 (2009).
87. H2 responses. Nature 458, 351-356 (2009).
88. H17 cell differentiation by antagonizing rOrγt function. Nature 453, 236-240 (2008).
89. Carneiro-Sampaio, M. & Coutinho, A. Tolerance and autoimmunity: lessons at the bedside of primary immunodeficiencies. Adv. Immunol. 95, 51-82 (2007). (Pubitemid 47380503)
90. Brusko, T.M., Putnam, A.L. & Bluestone, J.A. Human Regulatory T cells: role in autoImmune disease and therapeutic opportunities. Immunol. Rev. 223, 371-390 (2008).
91. The wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661-678 (2007).
92. Ridgway, W.M. et al. Gene-gene Interactions in the NOD mouse model of type 1 diabetes. Adv. Immunol. 100, 151-175 (2008).
93. Setoguchi, R., Hori, S., Takahashi, T. & Sakaguchi, S. Homeostatic maintenance of natural Foxp3+ CD25+ CD4+ Regulatory T cells by interleukin IL-2 and induction of autoImmune disease by IL-2 neutralization. J. Exp. Med. 201, 723-735 (2005).
94. Nagahama, K. et al. Differential control of allo-antigen-specific Regulatory T cells and Effector T cells by anti-CD4 and other agents in establishing transplantation tolerance. Int. Immunol. 21, 379-391 (2009).
95. Basu, S., Golovina, T., Mikheeva, T., June, C.H. & RIley, J.L. Cutting edge: Foxp3-mediated induction of Pim 2 allows human T Regulatory cells to preferentially expand in rapamycin. J. Immunol. 180, 5794-5798 (2008).
96. Strauss, L. et al. Selective survival of naturally ocCurring human CD4+CD25+Foxp3+ Regulatory T cells cultured with rapamycin. J. Immunol. 178, 320-329 (2007).
97. Liu, G. et al. The receptor S1P1 overrides Regulatory T cell-mediated Immune suppression through Akt-mTOR. Nat. Immunol. 10, 769-777 (2009).
98. Sawicka, E. et al. The sphingosine 1-phosphate receptor agonist FTY720 differen-tially affects the sequestration of CD4+/CD25+ T-Regulatory cells and enhances their functional activity. J. Immunol. 175, 7973-7980 (2005).
99. Wang, L., Tao, R. & Hancock, W.W. Using histone deacetylase inhibitors to enhance Foxp3+ Regulatory T-cell function and induce allograft tolerance. Immunol. Cell Biol. 87, 195-202 (2009).
100. Webster, K.E. et al. In vivo expansion of T reg cells with IL-2-mAb complexes: induction of resistance to eAe and long-term acceptance of islet allografts without immunosuppression. J. Exp. Med. 206, 751-760 (2009).
101. Luo, X. et al. Dendritic cells with TGF-β1 differentiate naive CD4+CD25-T cells into islet-protective Foxp3+ Regulatory T cells. Proc. Natl. Acad. Sci. USA 104, 2821-2826 (2007).